1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €1.30 (+983.33%). The median is €1.30 (+983.33%).
| Buy |
3 |
| Hold |
0 |
| Sell |
1 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 530.38k | 105.37% |
| Gross profit | 391.77k | 8,901.30% |
| Net profit | -4.16m | 24.33% |
| EBITDA | -2.84m | 7.44% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €6.28m |
Number of shares | 1.29m |
52-week high/low | €277.03 - €1.84 |
| Dividends | No |
Beta | 0.13 |
P/E ratio | 0.00 |
PEG ratio | 0.00 |
P/B ratio | 0.13 |
P/S ratio | 0.10 |
Company profile
| Name | Applied DNA Sciences |
| CEO | James A. Hayward Sc.D. |
| Employees | 46 |
